Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany The Tk Aims To Conclude Discount Contracts With All Suitable Pharmaceutical Companies According To § 130c Abs. 1 Sgb V For The Active Ingredient Combination Darunavir/cobicistat/emtricitabin/tenofovir Alafenamid. Darunavir, Cobicistat, Emtricitabin, Tenof 2026-02-18
Germany Open House Pharmaceutical Discounts On The Active Ingredient Rivaroxaban, Only Film -coated Tablets Excl. 2026-02-19
Germany The Tk Aims To Conclude Discount Contracts According To § 130c Abs. 1 Sgb V For The Active Ingredient Combination Darunavir/cobicistat/emtricitabin/tenofovir Alafenamid With All Suitable Pharmaceutical Companies. The Contract Conclusion Takes Place Within 2026-02-19
Ireland Hse 27385 Dynamic Purchasing System (dps) Invitation For The Supply Of Nrfit™ Consumable Products 2026-02-21
Germany Open House Medicinal Reduction Contracts For The Active Substance Rivaroxaban, Only Film Tablets Except. Active Strength 2.5 Mg, Atc B01af01, 67304 Eisenberg Rheinland-pfalz 2026-02-21
Germany Open House Medicinal Reduction Contracts For The Active Substance Rivaroxaban, Only Film Tablets Except. Active Strength 2.5 Mg, Atc B01af01, 67304 Eisenberg Rheinland-pfalz 2026-02-21
Thailand Announcement Of The Contest Of Employment Prices, Employment Services, Reading And Reporting Diagnostic Radiation Results For The Budget Year 2568 2026-02-21
Germany Non-excluding The Pharmaceutical Rabat Agreement According To § 130a Section 8 Sgb V By Means Of An Open-house Model On The Active Substance Omalizumab (atc Code According To Who: R03dx05) 2026-02-21
Germany Medicines With The Active Substance Eltrombopag (atc: B02bx05) 2026-02-21
Germany Eltrombopag (fast Oral Drf: Except The Indication Of Severe Aplastic Anemia)_tk, Hek, Hkk 2026-02-21
Whats app